Zaderej Karen L.

EyePoint Pharmaceuticals, Inc. · Director

Zaderej Karen L. is listed in filings as Director at EyePoint Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including purchase activity. Recent filings connect the profile to EyePoint Pharmaceuticals, Inc. (EYPT). The current snapshot covers public activity from Jul 12, 2024 to Jan 6, 2026. Reported amounts are shown as $699.2K to $29.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
EyePoint Pharmaceuticals, Inc.EYPT$29k5k sharesBuyMay 16, 2025$5.81$13.16
EyePoint Pharmaceuticals, Inc.EYPT$27k5k sharesBuyMay 15, 2025$5.47$13.16
EyePoint Pharmaceuticals, Inc.EYPT$27k5k sharesBuyMay 14, 2025$5.42$13.16
EyePoint Pharmaceuticals, Inc.EYPT$100k12.5k sharesBuyAug 19, 2024$7.98$13.16
Zaderej Karen L. History Trades | TradingNote